期刊文献+

保和汤加味治疗冠心病心绞痛52例 被引量:2

Clinical Observation on Effect of Jiawei Baohe Decoction in Treating 52 Case of Angina Pectoris
下载PDF
导出
摘要 目的观察保和汤加味治疗冠心病心绞痛的临床疗效。方法采用单盲对照法分为2组,均予基础治疗(西药),治疗组(52例)患者在基础治疗的同时使用保和汤加味内服,对照组(46例)患者在基础治疗的同时使用复方丹参片内服,用药2~4个疗程后进行随诊评定。结果2组总体疗效比较,治疗组明显优于对照组(P<0.05);对临床主要症状、心电图缺血性ST-T改变均有明显改善作用,且患者消心痛用量亦有明显减少,与对照组比较差异显著(P<0.05);对尿酸(UA)、高敏C-反应蛋白(HS-CRP)亦有明显降低作用,与对照组比较差异显著(P<0.05,P<0.01)。结论保和汤加味治疗冠心病心绞痛有良好效果。 Objective To observe the effect of Jiawei Baohe Decoction in treating Angina pectoris. Methods Single-blind control was adopted in this clinical observation, ninety-eight patients were divided into two groups, 52 in the treated group and 46 in control group. The two groups were treated by conventional therapy, combined with additional Jiawei Baohe Decoction(treated group) and compound dansheng tablets (control group) respectively for 2 to 4 courses. And the clinical effects as well as relevant criteria in both groups before and after treatment were observed. Results The total effective rate in the treated group was higher than that in the control group (P<0.05). And the clinical symptoms and ECG were improved significantly in treated group than those in contral group (P<0.05). The dosage of isosorbids dinitrate reduced markly in treated groups than in control group (P<0.05). The decrease of UA and HS-CRP levels was signiftcant in the treated group compared with the control group (P<0.05, P<0.01). Conclusion Jiawei Baohe Decoction has evident therapeutic effect in treating angia pectoris.
出处 《中国中医药信息杂志》 CAS CSCD 2005年第3期16-18,共3页 Chinese Journal of Information on Traditional Chinese Medicine
关键词 保和汤 冠心病心绞痛 Baohe decoction angina pectoris
  • 相关文献

参考文献5

  • 1方药中 等.实用中医内科学[M].上海:上海科学技术出版社,1985.306.
  • 2中华人民共和国卫生部.中药新药临床研究指导原则[S]:第1辑[M].,1993.41-45.
  • 3中华心血管病杂志编委会心血管病药物对策专题组.心血管病药物临床试验方法的建议—抗心肌缺血药.中华心血管病杂志,1998,26(6):405-413.
  • 4党爱民,刘国仗.尿酸与心血管事件[J].中华心血管病杂志,2003,31(6):478-480. 被引量:244
  • 5卓绮玲,林增文.高敏-CRP——心血管疾病的独立危险因子[J].国外医学(临床生物化学与检验学分册),2004,25(1):72-73. 被引量:40

二级参考文献45

  • 1Gertler MM, Garn SM, Levine SA. Serum Uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med, 1951,34 : 1421-1431.
  • 2Beard Jt. Serum uric acid and coronary heart disease. Am Heart J,1983,106:397-400.
  • 3Alderman MH, Cohen H, Madhavan S, et al. Serum uric acid and cardiovascular events in successfully treated hypertensive patients.Hypertension, 1999,34 : 144-150.
  • 4Bickel C, Rupprecht HI, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographical]y proven coronary artery disease. Am J Cardiol, 2002,89:12-17.
  • 5Brand FN, McGee DL, Kannel WB, et al. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol, 1985,121 : 11 -18.
  • 6Bonora E, Targher G, Zenete MB, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atheroaclerosis Risk Factors Study. Int J Obes Relat Metab Disord,1996,20:975-980.
  • 7Rathmann W, Funkhouser E, Dyer R, et al. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study.Coronary Artery Risk Development in Young Adults. Ann Epidemiol, 1998,8:250-261.
  • 8Ward HI. Uric acid as an independent risk factor in the treatment of hypertension.Lancet, 1998,352:670-671.
  • 9DeScheeder IK, van de Kraay AM, Lamers JM, et al. Myocardial malodialdehyde and uric acid release after short-lasting coronaryy occlusions during angioplasty: potential mechanisms for free radical generation. Am J Cardiol, 1991,68:392-395.
  • 10Ginsberg MH, Kozin F, O'Malley M. et al. Release of platelet constituents by monosodium urate crystals. J Clin Invest, 1997,60:999-1007.

共引文献533

同被引文献37

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部